SciDev.Net
Science and Development Network
News, views and information about science, technology and the developing world
Search Archive
Opinions archive results 1-20 of 28 in Health and Drug development
Biomed Analysis: To control or eradicate malaria?
Some scientists worry that renewed enthusiasm for malaria eradication could distract from vital control efforts, says Priya Shetty.
BioMed Analysis: Pooling patents for HIV drugs
A UNITAID patent pool could revolutionise HIV treatment and research in developing countries — if payment can be agreed, says Priya Shetty.
Home-grown vaccines are crucial for public health
Countries need to produce their own vaccines, and they need to invest in public sector capacity to do it, says Indian scientist Y. Madhavi.
OPINION | 23 September 2009 | EN
All countries deserve equal access to pandemic vaccines
Swine flu vaccines should be equally available, regardless of a country's ability to pay, says medical expert Tadataka Yamada.
OPINION | 18 August 2009 | EN
How to fill the gaps in global clinical research networks
Policymakers must think outside the box to strengthen clinical research networks for global health, says Harvard researcher Jeff Blander.
OPINION | 22 July 2009 | EN
Can early therapy prevent HIV?
More research is needed on how to tackle HIV with antiretroviral therapy, say Kevin M De Cock and colleagues at the WHO.
OPINION | 17 July 2009 | EN
'Lack of political will' to develop new vaccines
A lack of political will to create vaccines is causing millions of deaths a year due to infectious diseases, says Manuel Elkin Patarroyo.
OPINION | 28 May 2009 | ES
New tools to fight fake medicines
New technologies can help African countries identify counterfeit or substandard drugs, says director of Africa Fighting Malaria Roger Bate.
Medicinal biodiversity needs stronger protection efforts
International bodies, governments and indigenous people must all help protect medicinal biodiversity, say Jeffrey A. McNeely and Sue Mainka.
OPINION | 29 April 2009 | EN
Biotech industry can help tackle neglected diseases
The biotech industry has advantages over pharma for drug discovery for neglected diseases, say Joanna E. Lowell and Christopher D. Earl.
OPINION | 17 April 2009 | EN
Will Glaxo's big plans really benefit the poor?
GlaxoSmithKline plans to cut medicine prices and create a 'patent pool' — but does any of this reflect a real drive to boost the health of the poor?
OPINION | 6 March 2009 | EN
HIV/AIDS: A new hope
New and existing HIV/AIDS treatments provide hope that the disease can be eliminated, says an editorial in New Scientist.
New insecticides are crucial in battle against malaria
To sustain the fight against insect-borne diseases we must improve research funding for public health insecticides, says Roger Bate.
Priority review vouchers might not be the way forward
FDA priority review vouchers will not necessarily encourage research into tropical diseases, argues Aaron Kesselheim.
Progress in Chinese biomedicine a massive challenge
Developing biomedical research in China poses a massive challenge, says Zhu Chen.
Back to basics for malaria research
Funding agencies and donors hoping to tackle malaria must commit more to basic research, says Nature.
OPINION | 13 October 2008 | EN
Drug-resistant TB needs massive research increase
Multidrug-resistant TB needs more research to equip healthcare workers with the right tools, write Frank G. J. Cobelens and colleagues.
It's a long road to a H5N1 vaccine stockpile
Tadataka Yamada, Alice Dautry and Mark Walport want to see better coordination and financing for a global H5N1 virus vaccine stockpile.
Risk-averse researchers put mothers' lives at risk
Researchers are putting women's lives at risk by being too cautious about trialling drugs during pregnancy, say Nicholas J. White and colleagues.
Research deficiencies 'delaying HIV prevention'
Weaknesses in HIV research design have hindered progress in identifying prevention strategies, say Stephen W. Lagakos and Alicia R. Gable.
Information Services
Missed the Global Health Forum 2009?
Our blog, by SciDev.Net columnist Priya Shetty, will fill you in, as will our interview with the Global Forum's Gill Samuels
.jpg)
